Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth.
Osteogenic sarcoma is the most common bone tumor of childhood and typically occurs during the adolescent growth spurt when growth hormone and insulin-like growth factor I (IGF-I) may be at their lifetime highest levels. Since IGF-I is involved in normal bone growth and differentiation, we have evaluated the possible role of IGF-I signaling in the growth of human osteogenic sarcoma cell lines. In this study, we demonstrate that in vitro survival of cells is dependent on exogenously supplied IGF-I. Furthermore, we show that these cells display functional IGF-I receptors on their surface and that in vitro growth is inhibited by blocking these receptors either by monoclonal antibodies or by antisense oligonucleotides. These data demonstrate that human osteogenic sarcoma cell lines are dependent on signaling through the IGF-I receptor for in vitro survival and proliferation. Furthermore, they suggest that modulation of the growth hormone/IGF-I axis may affect the growth of these tumors in vivo.
Kappel
C C
CC
Molecular Oncology Section, National Cancer Institute, Bethesda, Maryland 20892.
Velez-Yanguas
M C
MC
Hirschfeld
S
S
Helman
L J
LJ
D002455:Cell Division; D002470:Cell Survival; D016895:Culture Media, Serum-Free; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D008899:Mineral Oil / Q000494:pharmacology; D012516:Osteosarcoma / Q000737:chemistry / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis; D012334:RNA, Neoplasm / Q000032:analysis; D017526:Receptor, IGF Type 1 / Q000032:analysis* / Q000187:drug effects / Q000502:physiology; D014407:Tumor Cells, Cultured
D016895:Culture Media, Serum-Free; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D007334:Insulin-Like Growth Factor I; D008899:Mineral Oil; D017526:Receptor, IGF Type 1